• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Signed Endorsement Letters for the Updated List of Vat-Exempt Medicines Under Republic Act 11534 known as Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act

The Food and Drug Administration (FDA) endorses to the Bureau of Internal Revenue (BIR) the updated list of VAT-Exempt Medicines (as of March 2022) under RA 11354, otherwise known as the Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.

List of VAT-exempt Drugs and Vaccines Prescribed and Directly Used for COVID-19 Treatment as of 01-22-2022

The DOH issues list of VAT-exempt drugs and vaccines prescribed and used for COVID-19 management

Consolidated List of VAT Exempt Products under TRAIN and CREATE Law

Consolidated List of VAT Exempt Products under TRAIN and CREATE Law as of September 6, 2021 Related Posts No post Found cOvid 19 Updates 16 Nov 2020 Philippine Standard time continue reading : Consolidated List of VAT Exempt Products under TRAIN and CREATE Law

Value Added Tax (VAT) Exempt Sales of Drugs and Medicines Prescribed for Diabetes, Hypertension and High Cholesterol Under Train Law

English Filipino English Filipino Related Posts Value Added Tax (VAT) Exemption on the Sale of Drugs 07 Oct 2020 Electronic Drug Price Monitoring System 21 Sep 2020 Maximum Retail Price continue reading : Value Added Tax (VAT) Exempt Sales of Drugs and Medicines Prescribed for Diabetes, Hypertension and High Cholesterol Under Train Law